You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relugolix

Showing 1 - 25 of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pregnancy Related, Pregnancy Complications, Pregnancy, High Risk Trial (Relugolix-Containing Product)

Not yet recruiting
  • Pregnancy Related
  • +2 more
  • Relugolix-Containing Product
  • (no location specified)
Feb 13, 2023

Prostate Cancer Trial in New Haven (Relugolix 120 MG [Orgovyx], SBRT standard of care radiotherapy treatment)

Not yet recruiting
  • Prostate Cancer
  • Relugolix 120 MG [Orgovyx]
  • SBRT standard of care radiotherapy treatment
  • New Haven, Connecticut
    Yale Cancer Center
Oct 26, 2023

Androgen Deprivation Therapy, Locally Advanced Prostate Cancer Trial in Oklahoma City (Relugolix and Enzalutamide)

Not yet recruiting
  • Androgen Deprivation Therapy
  • Locally Advanced Prostate Cancer
  • Relugolix and Enzalutamide
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center at OU Health, University of Oklahoma He
Nov 8, 2023

Prostate Cancer, Prostate Cancer Metastatic, Prostate Adenocarcinoma Trial (Relugolix Pill, Ritonavir, Itraconazole)

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Relugolix Pill
  • +2 more
  • (no location specified)
Dec 23, 2022

MYFEMBREE®: A Retrospective Cohort Study UsingAdministrative

Not yet recruiting
  • Pregnancy Related
  • +2 more
  • Relugolix + Estradiol + Norethindrone Acetate
  • (no location specified)
Feb 13, 2023

Prostate Cancer, Prostatic Tumors Trial in Boston, Foxboro (Relugolix, Leuprolide)

Not yet recruiting
  • Prostate Cancer
  • Prostatic Neoplasms
  • Boston, Massachusetts
  • +2 more
Mar 1, 2023

Uterine Fibroids, Endometriosis Trial (Relugolix Combination Tablet)

Not yet recruiting
  • Uterine Fibroids
  • Endometriosis
  • Relugolix Combination Tablet
  • (no location specified)
May 16, 2023

Prostate Cancer Trial in United States (Relugolix, Leuprolide Acetate)

Recruiting
  • Prostate Cancer
  • Relugolix
  • Leuprolide Acetate
  • Tucson, Arizona
  • +7 more
Feb 1, 2023

Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8 Trial in Kansas City

Not yet recruiting
  • Stage IIC Prostate Cancer AJCC v8
  • +2 more
  • Biospecimen Collection
  • +9 more
  • Kansas City, Kansas
    University of Kansas Cancer Center
Nov 3, 2023

Healthy Trial in Hialeah (Relugolix/E2/NETA FDC, Relugolix, Erythromycin)

Completed
  • Healthy
  • Relugolix/E2/NETA FDC
  • +2 more
  • Hialeah, Florida
    Clinical Pharmacology of Miami, An Evolution Research Group Port
Aug 30, 2021

Biochemically Recurrent Prostate Carcinoma, Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC v8 Trial in Atlanta

Recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • +10 more
  • Radiation therapy
  • +2 more
  • Atlanta, Georgia
  • +3 more
Jun 7, 2022

Healthy Trial in Minneapolis (Relugolix, E2/NETA)

Completed
  • Healthy
  • Minneapolis, Minnesota
    Clinical Study Site
Jul 20, 2021

Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Decatur, Effingham,

Recruiting
  • Oligometastatic Prostate Carcinoma
  • +2 more
  • Placebo Administration
  • +3 more
  • Decatur, Illinois
  • +2 more
Aug 11, 2022

Prostate Cancer Trial in Miami (FTLEAD, Ultra-Short-Term Androgen Deprivation Therapy with Relugolix, HypoLEAD)

Not yet recruiting
  • Prostate Cancer
  • FTLEAD
  • +3 more
  • Miami, Florida
    University of Miami
Oct 26, 2023

A Multi-Center, Prospective, Observational Study of Patients

Not yet recruiting
  • Prostate Cancer
  • Relugolix
  • (no location specified)
Jul 28, 2022

Prostate Cancer Trial in Baltimore (DFMO, testosterone cypionate, Luteinizing hormone-releasing hormone (LHRH) analogue)

Not yet recruiting
  • Prostate Cancer
  • Baltimore, Maryland
    Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Cen
Sep 22, 2023

Prostate Cancer, Stage IV Prostate Cancer Trial in Tampa (Luteinizing Hormone Releasing Hormone, New Hormonal Agent, Docetaxel)

Recruiting
  • Prostate Cancer
  • Stage IV Prostate Cancer
  • Luteinizing Hormone Releasing Hormone
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jun 1, 2022

Contraception Trial in United States (Relugolix Combination Therapy)

Recruiting
  • Contraception
  • Relugolix Combination Therapy
  • Birmingham, Alabama
  • +111 more
Jan 12, 2023

Endometriosis Related Pain Trial in Worldwide (Relugolix, Estradiol/norethindrone acetate, Estradiol/norethindrone acetate )

Completed
  • Endometriosis Related Pain
  • Relugolix
  • +3 more
  • Andalusia, Alabama
  • +90 more
Jun 25, 2021

Endometriosis Trial in Worldwide (Relugolix, Estradiol/norethindrone acetate)

Active, not recruiting
  • Endometriosis
  • Relugolix
  • Estradiol/norethindrone acetate
  • Andalusia, Alabama
  • +168 more
May 31, 2022

Endometriosis Related Pain Trial in Worldwide (Relugolix, Estradiol/norethindrone acetate, Estradiol/norethindrone acetate )

Completed
  • Endometriosis Related Pain
  • Relugolix
  • +3 more
  • Dothan, Alabama
  • +122 more
Jun 25, 2021

Prostate Cancer Trial in Worldwide (Relugolix, Leuprolide Acetate)

Completed
Has Results
  • Prostate Cancer
  • Relugolix
  • Leuprolide Acetate
  • Tucson, Arizona
  • +161 more
Jan 6, 2022

Prostate Cancer, Oligometastasis, Oligorecurrence Trial in United States (procedure, radiation, other, drug)

Recruiting
  • Prostate Cancer
  • +4 more
  • PET-directed Local Therapy using Surgery
  • +10 more
  • Long Beach, California
  • +15 more
Jul 29, 2022

Metrorrhagia, Pelvic Pain, Menorrhagia Trial in United States (Myfembree Oral Product)

Not yet recruiting
  • Metrorrhagia
  • +3 more
  • Myfembree Oral Product
  • Chicago, Illinois
  • +5 more
Sep 12, 2022

Heavy Menstrual Bleeding, Uterine Fibroid Trial in Worldwide (Relugolix, Estradiol/norethindrone acetate)

Completed
  • Heavy Menstrual Bleeding
  • Uterine Fibroid
  • Relugolix
  • Estradiol/norethindrone acetate
  • Andalusia, Alabama
  • +149 more
Jun 7, 2021